Xu Zhi Bin, Executive Chairman of Board of STAR Pharmaceutical acquired an additional 22.7% stake in STAR Pharmaceutical Limited (SGX:AYL) from Wang Qi for SGD 1.5 million on August 5, 2019. Xu Zhi Bin acquired 10.4 million at SGD 0.142 per share. The consideration is satisfied in cash. Pursuant to the transaction, Xu Zhi Bin raised its stake to 53.19% in STAR Pharmaceutical. In a related transaction, Xu Zhi Bin, made an offer to acquire remaining 46.8% stake in STAR Pharmaceutical Limited for SGD 9.7 million. Xu Zhi Bin, Executive Chairman of Board of STAR Pharmaceutical completed the acquisition of an additional 22.7% stake in STAR Pharmaceutical Limited (SGX:AYL) from Wang Qi on August 5, 2019.